Ardea Biosciences (RDEA) Inactive 10-K2005 FY Annual report

Filed: 21 Feb 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accurate, advisory, agriculture, appeal, articulated, assumption, byRule, capacity, Center, CFO, Chapter, claim, classification, concept, concomitant, confidence, deductible, Deloitte, dissolved, Embarcadero, entirety, FAS, Felix, FileNo, footnote, froze, FSP, Fuch, GP, Gregory, handle, hereto, Hickey, Hill, inSection, installment, instance, instrument, issueno, Julian, Lafayette, leave, long, Marketplace, mine, move, nonstatutorystock, Oak, ofRegulation, onForm, orRule, ourForm, Panel, Park, passed, PolyFuel, principle, promulgated, pronouncement, quickly, quotation, relationship, remedied, representation, SAB, Schafer, shell, simplify, tech, thisForm, Title, Touche, unusual, vi, vii

Removed: acceptance, accrual, achievement, adequate, adverse, anniversary, announced, arbitration, assure, auditing, bargaining, Bayshore, biopharmaceutical, cancel, candidate, cease, circumvented, collective, commence, commercialization, composition, confirming, conform, conserve, criteria, defending, delivery, detailed, dispensing, disposed, East, economic, enrollment, eventual, expanded, expensed, extensive, external, fact, failure, feet, finance, goal, hereof, human, identifiable, important, insufficient, left, line, loan, lot, meaningful, milestone, modified, molecular, monitor, obligated, patient, personnel, polypeptide, practicable, predict, qualified, ratifying, recommend, recover, recoverability, recoverable, redemption, rent, repayment, represented, requisite, scientific, scope, signature, space, square, store, study, subleased, subsequent, substitution, successful, supply, thereto, thereunder, therewith, thing, unable, undiscounted, vendor, work, worldwide

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

RDEA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 23.2

CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements (Forms S-3 Nos. 333-82934, 333-89840, 333-105288 and 333-110197) of IntraBiotics Pharmaceuticals, Inc. and in the related prospectuses, and in the Registration Statements (Forms S-8 Nos. 333-40524, 333-65616, 333-101632, 333-108096 and 333-117140) pertaining to the Amended and Restated 1995 Stock Option Plan, the 2000 Equity Incentive Plan, the 2000 Employee Stock Purchase Plan, the 2002 Non-Officer Equity Incentive Plan, the 2004 Stock Incentive Plan, and option agreements with Kathleen D. LaPorte and Ernest Mario Ph.D., of IntraBiotics Pharmaceuticals, Inc. of our report dated February 6, 2004, with respect to the 2003 financial statements of IntraBiotics Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2005.

/s/ ERNST & YOUNG, LLP
Palo Alto, California
February 16, 2006